{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Manyazewal T"],"funding":["FIC NIH HHS","NIAID NIH HHS","Medical Research Council"],"pagination":["101820"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9853306"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["56"],"pubmed_abstract":["Background
The success of a tuberculosis digital adherence technology relies on patients' satisfaction with and the usability of the technology. This study aimed to evaluate treatment satisfaction and usability of a digital medication event reminder and monitor (MERM) device for patients with tuberculosis to address the prespecified secondary endpoint of the SELFTB trial.Methods
In this multicenter, randomised controlled trial, adults (≥18 years) with new or previously treated, bacteriologically-confirmed, drug-sensitive pulmonary tuberculosis who were eligible to start anti-tuberculosis therapy were recruited from 10 healthcare facilities in Ethiopia. With a computer-generated random number sequence, participants were randomly assigned 1:1 to receive a 15-day tuberculosis "],"journal":["EClinicalMedicine"],"pubmed_title":["Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial."],"pmcid":["PMC9853306"],"funding_grant_id":["D43 TW009127","P30 AI168386","MR/M025470/1","P30 AI050409"],"pubmed_authors":["Getinet T","Fuad O","Manyazewal T","Getahun B","Fekadu A","Marconi VC","Bobosha K","Woldeamanuel Y","Holland DP","Hoover A"],"additional_accession":[]},"is_claimable":false,"name":"Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial.","description":"Background
The success of a tuberculosis digital adherence technology relies on patients' satisfaction with and the usability of the technology. This study aimed to evaluate treatment satisfaction and usability of a digital medication event reminder and monitor (MERM) device for patients with tuberculosis to address the prespecified secondary endpoint of the SELFTB trial.Methods
In this multicenter, randomised controlled trial, adults (≥18 years) with new or previously treated, bacteriologically-confirmed, drug-sensitive pulmonary tuberculosis who were eligible to start anti-tuberculosis therapy were recruited from 10 healthcare facilities in Ethiopia. With a computer-generated random number sequence, participants were randomly assigned 1:1 to receive a 15-day tuberculosis ","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2026-05-28T20:08:58.541Z","creation":"2025-02-19T04:45:43.212Z"},"accession":"S-EPMC9853306","cross_references":{"pubmed":["36684395"],"doi":["10.1016/j.eclinm.2022.101820"]}}